Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.19.3.a.u2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
12 Months Ended
Sep. 30, 2019
Sep. 30, 2018
OPERATING ACTIVITIES    
Net loss $ (12,017,366) $ (23,938,389)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 162,187 176,786
Amortization of intangible assets 309,234 275,262
Non-cash interest expense 4,706,056 2,950,501
Share-based compensation 1,906,098 1,638,505
Deferred income taxes (438,064) 630,150
Loss on settlement of accounts receivable   3,986,518
Provision for obsolete inventory 109,107 90,856
Change in fair value of derivative liabilities 1,199,000 (893,000)
Other 142,590 (2,756)
Changes in current assets and liabilities:    
(Increase) decrease in accounts receivable (1,351,709) 1,874,555
(Increase) decrease in inventory (1,454,483) 375,038
Increase in prepaid expenses and other assets (704,306) (65,570)
(Decrease) increase in accounts payable (56,938) 495,971
Decrease in unearned revenue (187,159) (487,068)
Increase in accrued expenses and other current liabilities 2,190,546 1,346,450
Net cash (used in) provided by operating activities (5,485,207) (11,546,191)
INVESTING ACTIVITIES    
Capital expenditures (108,517) (50,654)
Net cash used in investing activities (108,517) (50,654)
FINANCING ACTIVITIES    
Proceeds from sale of shares in public offering 9,400,000  
Payment of costs related to public offering (268,033)  
Proceeds from SWK credit agreement   10,000,000
Payment of debt issuance costs   (266,923)
Installment payments on SWK credit agreement (4,935,600) (642,485)
Proceeds from sale of shares under common stock purchase agreement 3,600,000 3,000,000
Payment of costs related to common stock purchase agreement   (77,840)
Proceeds from stock option exercises 333,000 66,000
Net cash provided by financing activities 8,129,367 12,078,752
Net increase in cash and cash equivalents 2,535,643 481,907
CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR 3,759,509 3,277,602
CASH AND CASH EQUIVALENTS AT END OF YEAR 6,295,152 3,759,509
Supplemental disclosure of cash flow Information:    
Cash paid for income taxes 303,582 222,223
Schedule of non-cash investing and financing activities:    
Shares issued in connection with common stock purchase agreement   347,081
Amortization of deferred costs related to common stock purchase agreement 101,981 84,984
Increase in other assets from accounts payable and accrued expenses   $ 190,000
Acquisition of equipment, furniture, and fixtures through capital lease $ 43,567